Genetics and Epigenetics of the Multifunctional Protein CTCF

Current Topics in Developmental Biology

Volumn 80, Issue , 2007, Pages 337-360

  Filippova, Galina N ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCCTC BINDING FACTOR; CCCTC-BINDING FACTOR; DNA BINDING PROTEIN; REPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; GENOME IMPRINTING; HUMAN; MALE; NEOPLASM; NUCLEOTIDE REPEAT; PHYSIOLOGY; REVIEW; TUMOR SUPPRESSOR GENE; X CHROMOSOME INACTIVATION;

ANIMALS; DNA METHYLATION; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, TUMOR SUPPRESSOR; GENOMIC IMPRINTING; HUMANS; MALE; MODELS, BIOLOGICAL; NEOPLASMS; REPETITIVE SEQUENCES, NUCLEIC ACID; REPRESSOR PROTEINS; X CHROMOSOME INACTIVATION;

EID: 35348924169     PISSN: 00702153     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0070-2153(07)80009-3     Document Type: Review

References (115)

1. Arnold R., Maueler W., Bassili G., Lutz M., Burke L., Epplen T.J., and Renkawitz R. The insulator protein CTCF represses transcription on binding to the (gt)(22)(ga)(15) microsatellite in intron 2 of the HLA-DRB1(*)0401 gene. Gene 253 (2000) 209-214
2. Awad T.A., Bigler J., Ulmer J.E., Hu Y.J., Moore J.M., Lutz M., Neiman P.E., Collins S.J., Renkawitz R., Lobanenkov V.V., and Filippova G.N. Negative transcriptional regulation mediated by thyroid hormone response element 144 requires binding of the multivalent factor CTCF to a novel target DNA sequence. J. Biol. Chem. 274 (1999) 27092-27098
3. Barski A., Cuddapah S., Cui K., Roh TY., Schones D.E., Wang Z., Wei G., Chepelev I., and Zhao K. High-resolution profiling of histone methylations in the human genome. Cell 129 (2007) 823-837
4. Baylin S. Mechanisms underlying epigenetically mediated gene silencing in cancer. Semin. Cancer Biol. 12 (2002) 331-337
5. Baylin S.B., and Ohm J.E. Epigenetic gene silencing in cancer-a mechanism for early oncogenic pathway addiction?. Nat. Rev. Cancer 6 (2006) 107-116
6. Bell A.C., and Felsenfeld G. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 405 (2000) 482-485
7. Bell A.C., West A.G., and Felsenfeld G. The protein CTCF is required for the enhancer blocking activity of vertebrate insulators. Cell 98 (1999) 387-396
8. Bell A.C., West A.G., and Felsenfeld G. Insulators and boundaries: Versatile regulatory elements in the eukaryotic genome. Science 291 (2001) 447-450 Review
9. Bergstrom R., Whitehead J., Kurukuti S., and Ohlsson R. CTCF regulates asynchronous replication of the imprinted H19/Igf2 domain. Cell Cycle 6 (2007) 450-454
10. Burcin M., Arnold R., Lutz M., Kaiser B., Runge D., Lottspeich F., Filippova G.N., Lobanenkov V.V., and Renkawitz R. Negative protein 1, which is required for function of the chicken lysozyme gene silencer in conjunction with hormone receptors, is identical to the multivalent zinc finger repressor CTCF. Mol. Cell. Biol. 17 (1997) 1281-1288
11. Burke L.J., Hollemann T., Pieler T., and Renkawitz R. Molecular cloning and expression of the chromatin insulator protein CTCF in Xenopus laevis. Mech. Dev. 113 (2002) 95-98
12. Burke L.J., Zhang R., Bartkuhn M., Tiwari V.K., Tavoosidana G., Kurukuti S., Weth C., Leers J., Galjart N., Ohlsson R., and Renkawitz R. CTCF binding and higher order chromatin structure of H19 locus are maintained in mitotic chromatin. EMBO J. 24 (2005) 3291-3300
13. Butcher D.T., and Rodenhiser D.I. Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumors. Eur. J. Cancer 43 (2007) 210-219
14. Butcher D.T., Mancini-DiNardo D.N., Archer T.K., and Rodenhiser D.I. DNA binding sites for putative methylation boundaries in the unmethylated region of the BRCA1 promoter. Int. J. Cancer 111 (2004) 669-678
15. Catteau A., and Morris J.R. BRCA1 methylation: A significant role in tumor development?. Semin. Cancer Biol. 12 (2002) 359-371
16. Chadwick B.P., and Willard H.F. Chromatin of the Barr body: Histone and non-histone proteins associated with or excluded from the inactive X chromosome. Hum. Mol. Genet. 12 (2003) 2167-2178 Epub. 2003 Jul 15
17. Chao W., Huynh K.D., Spenser R.J., Davidow L.S., and Lee J.T. CTCF, a candidate trans-acting factor for X-inactivation choice. Science 295 (2002) 345-347
18. Chen T., Sahin A., and Aldaz C.M. Deletion Map of Chromosome 16q in Ductal Carcinoma in situ of the Breast. Cancer Res. 56 (1996) 5605-5609
19. Chernukhin I., Shamsuddin S., Kang S.Y., Bergstrom R., Kwon Y.W., Yu W., Whitehead J., Mukhopadhyay R., Docquier F., Farrar D., Morrison I., Vigneron M., et al. CTCF interacts with and recruits the largest subunit of RNA polymerase II to CTCF target sites genome-wide. Mol. Cell. Biol. 27 (2007) 1631-1648
20. Chernukhin I.V., Shamsuddin S., Robinson A.F., Carne A.F., Paul A., El-Kady A.I., Lobanenkov V.V., and Klenova E.M. Physical and functional interaction between two pluripotent proteins, the Y-box DNA/RNA-binding factor, YB-1, and the multivalent zinc finger factor, CTCF. J. Biol. Chem. 275 (2000) 29915-29921
21. Cho D.H., Thienes C.P., Mahoney S.E., Analau E., Filippova G.N., and Tapscott S.J. Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF. Mol. Cell 20 (2005) 483-489
22. Choo Y., and Klug A. Physical basis of a protein-DNA recognition code. Curr. Opin. Struct. Biol. 7 (1997) 117-125
23. Cleton-Jansen A.M., Moerland E.W., Kuipers-Dijkshoorn N.J., Callen D.F., Sutherland G.R., Hansen B., Devilee P., and Cornelisse C.J. At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer. Genes Chrom. Cancer 9 (1994) 101-107
24. Collins C., Volik S., Kowbel D., Ginzinger D., Ylstra B., Cloutier T., Hawkins T., Predki P., Martin C., and Wernick M. Comprehensive genome sequence analysis of a breast cancer amplicon. Genome Res. 11 (2001) 1034-1042
25. Cui H., Niemitz E.L., Ravenel J.D., Onyango P., Brandenburg S.A., Lobanenkov V.V., and Feinberg V.V. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site. Cancer Res. 61 (2001) 4947-4950
26. Defossez P.A., Kelly K.F., Filion G.J., Perez-Torrado R., Magdinier F., Menoni H., Nordgaard C.L., Daniel J.M., and Gilson E. The human enhancer blocker CTCF-binding factor interacts with the transcription factor Kaiso. J. Biol. Chem. 280 (2005) 43017-43023
27. Dekker J., Rippe K., Dekker M., and Kleckner N. Capturing chromosome conformation. Science 295 (2002) 1306-1311
28. De La Rosa-Velazquez I.A., Rincon-Arano H., Benitez-Bribiesca L., and Recillas-Targa F. Epigenetic regulation of the human retinoblastoma tumor suppressor gene promoter by CTCF. Cancer Res. 67 (2007) 2577-2585
29. Disteche C.M., Filippova G.N., and Tsuchiya K.D. Escape from X inactivation. Cytogenet. Genome Res. 99 (2002) 36-43
30. Dobrovic A., and Simpfendorfer D. Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res. 57 (1997) 3347-3350
31. Docquier F., Farrar D., D'Arcy V., Chernukhin I., Robinson A.F., Loukinov D., Vatolin S., Pack S., Mackay A., Harris R.A., Dorricott H., O'Hare M.J., et al. Heightened expression of CTCF in breast cancer cells is associated with resistance to apoptosis. Cancer Res. 65 (2005) 5112-5122
32. Donohoe M.E., Zhang L.F., Xu N., Shi Y., and Lee J.T. Identification of a Ctcf cofactor, Yy1, for the X chromosome binary switch. Mol. Cell 25 (2007) 43-56
33. Dunn K.L., Zhao H., and Davie J.R. The insulator binding protein CTCF associates with the nuclear matrix. Exp. Cell Res. 288 (2003) 218-223
34. Engel N., Thorvaldsen J.L., and Bartolomei M. CTCF binding sites promote transcription initiation and prevent DNA methylation on the maternal allele at the imprinted H19/Igf2 locus. Hum. Mol. Genet. 15 (2006) 2945-2954
35. Esteller M. Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br. J. Cancer 94 (2006) 179-183
36. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat. Rev. Genet. 8 (2007) 286-298
37. Fedoriw A.M., Stein P., Svoboda P., Schultz R.M., and Bartolomei M.S. Transgenic RNAi reveals essential function for CTCF in H19 gene imprinting. Science 303 (2004) 238-240
38. Feinberg A.P. Cancer epigenetics takes center stage. Proc. Natl. Acad. Sci. USA 98 (2001) 392-394
39. Feinberg A.P., and Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301 (1983) 89-92
40. Feinberg A., Cui H., and Ohlsson R. DNA methylation and genomic imprinting: Insights from cancer into epigenetic mechanisms. Semin. Cancer Biol. 12 (2002) 389-398
41. Feinberg A.P., Ohlsson R., and Henikoff S. The epigenetic progenitor origin of human cancer. Nat. Rev. Genet. 7 (2006) 21-33
42. Filippova G.N., Fagerlie S., Klenova E.M., Myers C., Dehner Y., Goodwin G., Neiman P.E., Collins S.J., and Lobanenkov V.V. An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes. Mol. Cell. Biol. 16 (1996) 2802-2813
43. Filippova G.N., Lindblom A., Meincke L.J., Klenova E.M., Neiman P.E., Collins S.J., Doggett N.A., and Lobanenkov V.V. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers. Genes Chrom. Cancer 22 (1998) 26-36
44. Filippova G.N., Thienes C., Penn B., Cho D., Hu Y.J., Moore J.M., Klesert T.R., Lobanenkov V.V., and Tapscott S.J. CTCF sites flank CTG/CAG repeats and form a methylation-sensitive insulator at the DM1 locus. Nat. Genet. 28 (2001) 335-343
45. Filippova G.N., Qi C.-F., Ulmer J., Moore J.M., Hu Y.J., Ward M.D., Hu Y.J., Loukinov D.I., Pugacheva E.M., Klenova E.M., Grundy P.E., Feinberg A.P., et al. Tumor-associated zinc finger mutations in the CTCF transcription factor selectively alter its DNA-binding specificity. Cancer Res. 62 (2002) 48-52
46. Filippova G.N., Cheng M.K., Moore J.M., Truong J.-P., Hu Y.J., Nguen D.K., Tsuchiya K.D., and Disteche C.M. Boundaries between chromosomal domains of X inactivation and escape bind CTCF and lack CpG methylation during early development. Dev. Cell 8 (2005) 31-42
47. Fitzpatrick G.V., Pugacheva E.M., Shin J.-Y., Abdullaev Z., Yang Y., Khatod K., Lobanenkov V.V., and Higgins M.J. Allele-specific binding of CTCF to the multipartite imprinting control region KvDMR1. Mol. Cell. Biol. 27 (2007) 2636-2647
48. Frengen E., Rocca-Serra P., Shaposhnikov S., Taine L., Thorsen J., Bepoldin C., Krekling M., Lafon D., Aas K.K., El Moneim A.A., Johansen H., Longy M., et al. High-resolution integrated map encompassing the breast cancer loss of heterozygosity region on human chromosome 16q22.1. Genomics 70 (2000) 273-285
49. Fujii H., Szumel R., Marsh C., Zhou W., and Gabrielson E. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast. Cancer Res. 56 (1996) 5260-5265
50. Gaszner M., and Felsenfeld G. Insulators: Exploring transcriptional and epigenetic mechanisms. Nat. Rev. Genet. 7 (2006) 703-713
51. Gerasimova T.I., Byrd K., and Corces V.G. A chromatin insulator determines the nuclear localization of DNA. Mol. Cell 6 (2000) 1025-1035
52. Gerasimova T.I., and Corces V.G. Chromatin insulators and boundaries: Effects on transcription and nuclear organization. Annu. Rev. Genet. 35 (2001) 193-208
53. Gray C.E., and Coates C.J. Cloning and characterization of cDNAs encoding putative CTCFs in the mosquitoes, Aedes aegypti and Anopheles gambiae. BMC Mol. Biol. 6 (2005) 16
54. Hark A.T., Schoenherr C.J., Katz D.J., Ingram R.S., Levorse J.M., and Tilghman S.M. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 405 (2000) 486-489
55. Holmgren C., Kanduri C., Dell G., Ward A., Mukhopadhya R., Kanduri M., Lobanenkov V., and Ohlsson R. CpG methylation regulates the IGF2/H19 insulator. Curr. Biol. 11 (2001) 1128-1130
56. Ishihara K., Oshimura M., and Nakao M. CTCF-dependent chromatin insulator linked to epigenetic remodeling. Mol. Cell 23 (2006) 733-742
57. Issa J.-P. CpG island methylator phenotype in cancer. Nat. Rev. Cancer 4 (2004) 988-993
58. Iwabuchi H., Sakamoto M., Sakunaga H., Ma Y.Y., Carcangiu M.L., Pinkel D., Yang-Feng T.L., and Gray J.W. Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res. 55 (1995) 6172-6180
59. Jelinic P., Stehle J.C., and Shaw P. The testis-specific factor CTCFL cooperates with the protein methyltransferase PRMT7 in H19 imprinting control region methylation. PLoS Biol. 4 (2006) 355
60. Jones P. DNA methylation and cancer. Oncogene 21 (2002) 5358-5360
61. Kanduri C., Pant V., Loukinov D., Pugacheva E., Qi C.F., Wolffe A., Ohlsson R., and Lobanenkov V.V. Functional association of CTCF with the insulator upstream of the H19 gene is parent of origin-specific and methylation-sensitive. Curr. Biol. 10 (2000) 853-856
62. Kanduri M., Kanduri C., Mariano P., Vostrov A.A., Quitschke W., Lobanenkov V., and Ohlsson R. Multiple nucleosome positioning sites regulate the CTCF-mediated insulator function of the H19 imprinting control region. Mol. Cell. Biol. 22 (2002) 3339-3344
63. Kim T.H., Abdullaev Z.K., Smith A.D., Ching K.A., Loukinov D.I., Green R.D., Zhang M.Q., Lobanenkov V.V., and Ren B. Analysis of the vertebrate insulator protein CTCF-binding sites in the human genome. Cell 128 (2007) 12341-12345
64. Klenova E., and Ohlsson R. Poly(ADP-ribosyl)ation and epigenetics. Is CTCF PARt of the plot?. Cell Cycle 4 (2005) 96-101 Review
65. Klenova E.M., Nicolas R.H., Paterson H.F., Carne A.F., Heath C.M., Goodwin G.H., Neiman P.E., and Lobanenkov V.V. CTCF, a conserved nuclear factor required for optimal transcriptional activity of the chicken c-myc gene, is an 11-Zn-finger protein differentially expressed in multiple forms. Mol. Cell. Biol. 13 (1993) 7612-7624
66. Klenova E.M., Chernukhin I.V., El-Kady A., Lee R.E., Pugacheva E.M., Loukinov D.I., Goodwin G.H., Delgado D., Filippova G.N., León J., Morse III H.C., Neiman P.E., et al. Functional phosphorylation sites in the C-terminal region of the multivalent multifunctional transcriptional factor CTCF. Mol. Cell. Biol. 21 (2001) 2221-2234
67. Klenova E.M., Morse III H.C., Ohlsson R., and Lobanenkov V.V. The novel BORIS + CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer. Semin. Cancer Biol. 12 (2002) 399-414 Review
68. Krueger C., and Osborne C.S. Raising the curtains on interchromosomal interactions. Trends Genet. 22 (2006) 637-639
69. Kurukuti S., Tiwari V.K., Tavoosidana G., Pugacheva E., Murrell A., Zhao Z., Lobanenkov V., Reik W., and Ohlsson R. CTCF binding at the H19 imprinting control region mediates maternally inherited higher-order chromatin conformation to restrict enhancer access to Igf2. Proc. Natl. Acad. Sci. USA 103 (2006) 10684-10689
70. Latil A., Cussenot O., Fournier G., Driouch K., and Lidereau R. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma. Cancer Res. 57 (1997) 1058-1062
71. Lewis A., and Murrell A. Genomic imprinting: CTCF protects the boundaries. Curr. Biol. 14 (2004) R284-R286 Review
72. Ling J.Q., Li T., Hu J.F., Vu T.H., Chen H.L., Qiu X.W., Cherry A.M., and Hoffman A.R. CTCF mediates interchromosomal colocalization between Igf2/H19 and Wsb1/Nf1. Science 312 (2006) 269-272
73. Lingenfelter P.A., Adler D.A., Poslinski D., Thomas S., Elliott R.W., Chapman V.M., and Disteche C.M. Escape from X inactivation of Smcx is preceded by silencing during mouse development. Nat. Genet. 18 (1998) 212-213
74. Lobanenkov V.V., Nicolas R.H., Adler V.V., Klenova E.M., Polotskaja A.V., and Goodwin G.H. A novel sequence-specific DNA binding protein which interacts with three regularly spaced direct repeats of the CCCTC-motif in the 5′-flanking sequence of the chicken c-myc gene. Oncogene 5 (1990) 1743-1753
75. Loukinov D.I., Pugacheva E., Vatolin S., Pack S.D., Moon H., Chernukhin I., Mannan P., Larsson E., Kanduri C., Vostrov A.A., Cui H., Niemitz E.L., et al. BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma. Proc. Natl. Acad. Sci. USA 99 (2002) 6806-6811
76. Lutz M., Burke L.J., LeFevre P., Myers F.A., Thorne A.W., Crane-Robinson C., Bonifer C., Filippova G.N., Lobanenkov V., and Renkawitz R. Thyroid hormone-regulated enhancer blocking: Cooperation of CTCF and thyroid hormone receptor. EMBO J. 22 (2003) 1579-1587
77. Martens J.H.A., O'Sullivan R.J., Braunschweig U., Opravil S., Radolf M., Steinlein P., and Jenuwein T. The profile of repeat-associated histone lysine methylation states in the mouse epigenome. EMBO J. 24 (2005) 800-812
78. Maw M.A., Grundy P.E., Millow L.J., Eccles M.R., Dunn R.S., Smith P.J., Feinberg A.P., Law D.J., Paterson M.C., Telzerow P.E., Callen D.F., Thompson A.D., et al. A third Wilms' tumor locus on chromosome 16q. Cancer Res. 52 (1992) 3094-3098
79. Moon H., Filippova G., Loukinov D., Pugacheva E., Chen Q., Smith S., Munhall A., Grewe B., Bartkuhn M., Arnold R., Burke L., Renkawitz-Phol R., et al. CTCF is conserved from Drosophila to humans and confers enhancer blocking of the Fab-8 insulator. EMBO Reports 6 2 (2005) 165-170
80. Mukhopadhyay R., Yu W., Whitehead J., Xu J., Lezcano M., Pack S., Kanduri C., Kanduri M., Ginjala V., Vostrov A., Quitschke W., Chernukhin I., et al. The binding sites for the chromatin insulator protein CTCF map to DNA methylation-free domains genome-wide. Genome Res. 14 (2004) 1594-1602
81. Mummert S.K., Lobanenkov V.A., and Feinberg A.P. Association of chromosome arm 16q loss with loss of imprinting of insulin-like growth factor-II in Wilms tumor. Genes Chrom. Cancer 43 (2005) 155-161
82. Murrell A., Heeson S., and Reik W. Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops. Nat. Genet. 36 (2004) 889-893
83. Nakagawa H., Chadwick R.B., Peltomaki P., Plass C., Nakamura Y., and de La Chapelle A. Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. Proc. Natl. Acad. Sci. USA 98 (2001) 591-596
84. Navarro P., Page D.R., Avner P., and Rougeulle C. Tsix-mediated epigenetic switch of a CTCF-flanked region of the Xist promoter determines the Xist transcription program. Genes Dev. 20 (2006) 2787-2792
85. Ogawa O., Eccles M.R., Szeto J., McNoe L.A., Yun K., Maw M.A., Smith P.J., and Reeve A.E. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 362 (1993) 749-751
86. Ohlsson R., Renkawitz R., and Lobanenkov V. CTCF is a uniquely versatile transcriptional regulator with diverse functions linked to epigenetics and disease. Trends Genet. 24 (2001) 3497-3504
87. Otten A.D., and Tapscott S.J. Triplet repeat expansion in myotonic dystrophy alters the adjacent chromatin structure. Proc. Natl. Acad. Sci. USA 92 (1995) 5465-5469
88. Pant V., Kurukuti S., Pugacheva E., Shamsuddin S., Mariano P., Renkawitz R., Klenova E., Lobanenkov V., Ohlsson R., Pant V., Kurukuti S., Pugacheva E., et al. Mutation of a single CTCF site within the H19 ICR leads to loss of Igf2 imprinting and complex patterns of de novo methylation upon maternal inheritance. Mol. Cell. Biol. 24 (2004) 3497-3504
89. Pugacheva E.M., Tiwari V.K., Abdullaev Z., Vostrov A.A., Flanagan P.T., Quitschke W.W., Loukinov D.I., Ohlsson R., and Lobanenkov V.V. Familial cases of point mutations in the XIST promoter reveal a correlation between CTCF binding and pre-emptive choices of X chromosome inactivation. Hum. Mol. Genet. 14 (2005) 953-965
90. Pugacheva E.M., Kwon Y.W., Hukriede N.A., Pack S., Flanagan P.T., Ahn J.C., Park J.A., Choi K.S., Kim K.W., Loukinov D., Dawid I.B., and Lobanenkov V.V. Cloning and characterization of zebrafish CTCF: Developmental expression patterns, regulation of the promoter region, and evolutionary aspects of gene organization. Gene 375 (2006) 26-36
91. Rakha E.A., Armour J.A., Pinder S.E., Paish C.E., and Ellis I.O. High-resolution analysis of 16q22.1 in breast carcinoma using DNA amplifiable probes (multiplex amplifiable probe hybridization technique) and immunohistochemistry. Int. J. Cancer 114 (2005) 720-729
92. Rasko J.E., Klenova E.M., Leon J., Filippova G.N., Loukinov D.I., Vatolin S., Robinson A.F., Hu Y.J., Ulmer J., Ward M.D., Pugacheva E.M., Neiman P.E., et al. Cell growth inhibition by the multifunctional multivalent zinc-finger factor CTCF. Cancer Res. 61 (2001) 6002-6007
93. Recillas-Targa F., Pikaart M.J., Burgess-Beusse B., Bell A.C., Litt M.D., West A.G., Gaszner M., and Felsenfeld G. Position-effect protection and enhancer blocking by the chicken beta-globin insulator are separable activities. Proc. Natl. Acad. Sci. USA 99 (2002) 6883-6888
94. Reddy P.S., and Housman D.E. The complex pathology of trinucleotide repeats. Curr. Opin. Cell Biol. 9 (1997) 364-372
95. Renaud S., Loukinov D., Bosman F.T., Lobanenkov V., and Benhattar J. CTCF binds the proximal exonic region of hTERT and inhibits its transcription. Nucleic Acids Res. 33 (2005) 6850-6860
96. Sakatani T., Kaneda A., Iacobuzio-Donahue C.A., Carter M.G., de Boom Witzel S., Okano H., Ko M.S., Ohlsson R., Longo D.L., and Feinberg A.P. Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice. Science 307 (2005) 1976-1978
97. Schoenherr C.J., Levorse J.M., and Tilghman S.M. CTCF maintains differential methylation at the Igf2/H19 locus. Nat. Genet. 33 (2002) 66-69
98. Spilianakis C.G., and Flavell R.A. Managing associations between different chromosomes. Science 312 (2006) 207-208
99. Splinter E., Heath H., Kooten J., Palstra R.-J., Klous P., Grosveld F., Galjart N., and de Laat W. CTCF mediates long-range chromatin looping and local histone modification in the β-globin locus. Genes Dev. 20 (2006) 2349-2354
100. Suzuki H., Komiya A., Emi M., Kuramochi H., Shiraishi T., Yatani R., and Shimazaki J. Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers. Genes Chrom. Cancer 17 (1996) 225-233
101. Talbert P.B., and Henikoff S. Spreading of silent chromatin: Inaction at a distance. Nat. Rev. Gen. 7 (2006) 793-803
102. Tam A.S., Devereux T.R., and Patel A.C. Perturbations of the Ink4a/Arf gene locus in aflatoxin B-induced mouse lung tumors. Carcinogenesis 24 (2003) 121-132
103. Tapscott S.J. Deconstructing myotonic dystrophy. Science 289 (2000) 1701-1702
104. Tycko B. Genomic imprinting and cancer. Results Probl. Cell Differ. 25 (1999) 133-169
105. Vatolin S., Abdullaev Z., Pack S.D., Flanagan P.T., Flanagan P.T., Custer M., Loukinov D.I., Pugacheva E., Hong J.A., Morse III H., Schrump D.S., Risinger J.I., et al. Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes. Cancer Res. 65 (2005) 7751-7762
106. Vostrov A.A., and Quitschke W.W. The zinc finger protein CTCF binds to the APBbeta domain of the amyloid beta-protein precursor promoter. Evidence for a role in transcriptional activation. J. Biol. Chem. 272 (1997) 33353-33359
107. West A.G., Gaszner M., and Felsenfeld G. Insulators: Many functions, many mechanisms. Genes Dev. 16 (2002) 271-288
108. Yang Y., Quitschke W.W., Vostrov A.A., and Brewer G.J. CTCF is essential for up-regulating expression from the amyloid precursor protein promoter during differentiation of primary hippocampal neurons. J. Neurochem. 73 (1999) 2286-2298
109. Yeh A., Wei M., Golub S.B., Yamashiro D.J., Murty V.V., and Tycko B. Chromosome arm 16q in Wilms tumors: Unbalanced chromosomal translocations, loss of heterozygosity, and assessment of the CTCF gene. Genes Chromosomes Cancer 35 2 (2002) 156-163
110. Yoon B., Herman H., Hu B., Park Y.J., Lindroth A., Bell A., West A.G., Chang Y., Stablewski A., Piel J.C., Loukinov D.I., Lobanenkov V.V., et al. Rasgrf1 imprinting is regulated by a CTCF-dependent methylation-sensitive enhancer blocker. Mol. Cell. Biol. 25 (2005) 11184-11190
111. Yu W., Ginjala V., Pant V., Chernukhin I., Whitehead J., Docquier F., Farrar D., Tavoosidana G., Mukhopadhyay R., Kanduri C., Oshimura M., Feinberg A.P., et al. Poly(ADP-ribosyl)ation regulates CTCF-dependent chromatin insulation. Nat. Genet. 36 (2004) 1105-1110
112. Yusufzai T.M., and Felsenfeld G. The 5′-HS4 chicken beta-globin insulator is a CTCF-dependent nuclear matrix-associated element. Proc. Natl. Acad. Sci. USA 101 (2004) 8620-8624
113. Yusufzai T.M., Tagami H., Nakatani Y., and Felsenfeld G. CTCF tethers an insulator to subnuclear sites, suggesting shared insulator mechanisms across species. Mol. Cell 13 (2004) 291-298
114. Zhao H., and Dean A. An insulator blocks spreading of histone acetylation and interferes with RNA polymerase II transfer between an enhancer and gene. Nucleic Acids Res. 32 (2004) 4903-4919
115. Zhou X.L., Werelius B., and Lindblom A. A screen for germ line mutations in the gene encoding CCCTC-binding factor (CTCF) in familial non-BRCA1/BRCA2 breast cancer. Breast Cancer Res. 6 (2004) R187-R190